The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors-Reference-Cited by-同舟云学术

The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors

Published:2013-06 Issue:6 Volume:27 Page:469-478
ISSN:1172-7047
Container-title:CNS Drugs
language:en
Short-container-title:CNS Drugs

Author:

Grossberg George T.,Manes Facundo,Allegri Ricardo F.,Gutiérrez-Robledo Luis Miguel,Gloger Sergio,Xie Lei,Jia X. Daniel,Pejović Vojislav,Miller Michael L.,Perhach James L.,Graham Stephen M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Psychiatry and Mental health,Clinical Neurology

Link

http://link.springer.com/article/10.1007/s40263-013-0077-7/fulltext.html

Reference43 articles.

1. Langa KM, Chernew ME, Kabeto MU, Herzog AR, Ofstedal MB, Willis RJ, et al. National estimates of the quantity and cost of informal caregiving for the elderly with dementia. J Gen Intern Med. 2001;16(11):770–8.

2. Mohamed S, Rosenheck R, Lyketsos CG, Schneider LS. Caregiver burden in Alzheimer disease: cross-sectional and longitudinal patient correlates. Am J Geriatr Psychiatry. 2010;18(10):917–27.

3. Herrmann N, Tam DY, Balshaw R, Sambrook R, Lesnikova N, Lanctot KL. The relation between disease severity and cost of caring for patients with Alzheimer disease in Canada. Can J Psychiatry. 2010;55(12):768–75.

4. Small GW, McDonnell DD, Brooks RL, Papadopoulos G. The impact of symptom severity on the cost of Alzheimer’s disease. J Am Geriatr Soc. 2002;50(2):321–7.

5. Hughes CM. Medication non-adherence in the elderly: how big is the problem? Drugs Aging. 2004;21(12):793–811.

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Mechanisms and Therapeutic Approaches of Mitochondrial Dysfunction in Alzheimer’s Disease: An Educational Literature Review;Molecular Neurobiology;2024-09-10

2. Efficacy of 5 and 10 mg donepezil in improving cognitive function in patients with dementia: a systematic review and meta-analysis;Frontiers in Neuroscience;2024-07-22

3. Adverse event profile of memantine and donepezil combination therapy: a real-world pharmacovigilance analysis based on FDA adverse event reporting system (FAERS) data from 2004 to 2023;Frontiers in Pharmacology;2024-07-17

4. Pro-cognitive effects of dual tacrine derivatives acting as cholinesterase inhibitors and NMDA receptor antagonists;Biomedicine & Pharmacotherapy;2024-07

5. Conditioned Media Therapy in Alzheimer's Disease: Current Findings and Future Challenges;Current Stem Cell Research & Therapy;2024-07